Voyager Therapeutics (NASDAQ: $VYGR) is a pioneer biotechnology company with a prime focus on developing treatments for severe neurological diseases. Moreover, the company has advanced […]
Category: Biotech
CRISPR Therapeutics AG (NASDAQ: $CRSP) Gets Green Light to Commercialize Their Gene Therapy for Sickle Cell Disease
CRISPR Therapeutics AG (NASDAQ: CRSP) is a leader in gene editing technology. The company is working on cures for serious diseases using its proprietary gene-editing […]
Compugen Ltd. (NASDAQ: $CGEN) Gains 200%+ On Tuesday
Compugen Ltd. (NASDAQ: CGEN) is a clinical-stage, data-science-driven drug discovery biotech firm that is working on therapeutics in cancer immunotherapy. To achieve its goal, the […]
Moderna, Inc. (NASDAQ: $MRNA) Soars on Cancer Vaccine Data
Moderna (NASDAQ: $MRNA) stock experienced a surge of approximately 14% on Thursday following news that its personalized cancer vaccine, developed in collaboration with Merck (MRK), […]
Vertex Pharmaceuticals (NASDAQ: $VRTX) Jumps on Phase 2 Results For Opioid Alternative
Vertex Pharmaceuticals (NASDAQ: $VRTX) released encouraging results from its Phase 2 trial of a pain medication designed to address diabetic peripheral neuropathy (DPN) on Wednesday. […]
Aditxt, Inc. (NASDAQ: $ADTX) Enters into Definitive Agreement to Acquire Evofem Biosciences
Aditxt, Inc. (NASDAQ: ADTX) is a life science company working on technologies to improve the immune system health. The company is developing immune reprogramming and […]